Candela Nordlys Laser Reverses Skin Aging
Analysis based on 9 articles · First reported Jun 30, 2026 · Last updated Jun 30, 2026
The market for medical aesthetic devices and regenerative medicine is expected to see increased interest and investment due to the scientific validation of Candela Corporation's Nordlys laser. This breakthrough could lead to higher demand for Candela Corporation's products and potentially influence research and development in related fields, benefiting companies like Mitra Bio involved in epigenetic research.
A new peer-reviewed study published in Scientific Reports (Nature Portfolio) provides the first in vivo human evidence that Candela Corporation's Nordlys 1940 nm non-ablative fractional laser remodels the skin's epigenome, reversing age-associated DNA methylation. The research, conducted in partnership with Mitra Bio and the Candela Institute for Excellence, demonstrated that the treatment not only improves visible signs of aging but also has a direct molecular link to skin cancer biology by positively modulating DNA methylation at keratinocyte-regulating loci. The study involved 22 adults over nine months, showing progressive and durable molecular changes that paralleled visible improvements in brown spots, texture, and overall pigmentation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard